Skye Bioscience, Inc. (SKYE) stock

SKYENasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30

$1.09+0.01 (+0.93%)

Close on Nov 13, 2026Market cap $4.82MP/E –Yield –

Skye Bioscience total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Skye Bioscience's total debt was $71.10K at Sep 30, 2020.

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q3 FY2020	Sep 30, 2020	$71.10K	–
Q2 FY2020	Jun 30, 2020	$51.65K	–

See a number that looks wrong?